Kamaldeep Chawla Email and Phone Number

Leading client engagement to provide secondary data solutions for regulatory and non-regulatory real-world evidence (RWE) requirements including safety (PASS), drug utilisation, external comparator and epidemiological studiesResponsible to drive business growth from early engagement to full scope real world study award, contracting and beyondDriving engagement with internal and external data providers across Europe including national registers, disease registers, claims and EMR data providersReceived impact award in 2023 for revitalising business pipeline with a mid-size pharma company

Led data driven story to minimize operational risks in real-world studies, including post-authorization safety & efficacy studies, disease and product registries, low-interventional studiesLeveraged data and analytics solutions to recommend the right countries, build patient enrolment scenarios, select ideal sites and investigators, recommend mitigation strategy for studies facing enrolment challenges

Led a team of 7 direct reports to deliver 1000 patient density analytics in 8-months, covering 100 disease areas in 20 countries, leading to launch of automated analytics offering for IQVIA R&D operationsLed the expansion of global analytics team’s capabilities to 5 new countries, understood country data breadth-depth and limitations, built analytics methodology for data scientists to scale, established data-privacy guidelines for end-use cases in the teamAwarded “CEO Award 2018” and “Nakshatra Award 2018”, for stellar performance in building automated analytics offering

Delivered data-driven site and investigator analytics for clinical study teams to drive site selection and meet recruitment targets

Strategy and market intelligence support to regional and national therapy teams of a large European accountBuilt end-to-end understanding of IQVIA MIDAS pharmacy and hospital sales audits in >100 countries, sales channels, data projections, limitations, and standardization factors

Led and delivered in-depth research on strategic imperatives behind licensing and acquisition deals in pharmaceutical industry, such as portfolio gaps, geographic and therapeutic expansion, technology requirements

Established a new analyst services offering for niche client segments including pre-commercial biotech companies and financial institutions, USP of the service was quick turn-around to business questions by BU heads and strategy leads in client organizationsAuthored “Emerging Market Opportunities” reports covering high-growth potential pharmaceutical companies in India and Latin America

Delivered a wide range of market research and strategy projects for big pharma clients in areas including business development & licensing, therapy area prioritization, market assessment, sales forecast, and product life cycle managementAwarded ‘Best Performer in Team for the year 2012

Worked on pre-clinical data analysis using MATLAB-7 and STATISTICA 7 & Artifical Neural Network (ANN). Accomplished tool development for pre-clinical toxicity assessment of an NCE.